1,034 results on '"Ohno, R."'
Search Results
2. Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus
3. AB0147 ANTI-FIBROTIC EFFECTS OF MT-5562, A NOVEL POTENT SELECTIVE AUTOTAXIN INHIBITOR, IN PRECLINICAL STUDIES: CLUES TO TREAT SKIN AND LUNG FIBROSIS IN SYSTEMIC SCLEROSIS
4. Recent Progress of Liquid Nitrogen Cooling System (LINCS) for Yokohama HTS Cable Project
5. Trial to Extract Prognostic Factors Prior to the Start of Induction Chemotherapy for Adult AML
6. A Double-blind Controlled Study of G-CSF Started Two Days Before Induction Chemotherapy in Refractory Acute Myeloid Leukemia
7. G-CSF after Intensive Induction Chemotherapy in Refractory Acute Leukemia and Bone Marrow Transplantation in Myeloid Leukemia
8. Granulocyte Colony-Stimulating Factor in the Therapy of Myeloid Leukemia
9. Cold-specific and light-stimulated expression of a wheat (Triticum aestivum L.) Cor gene Wcor15 encoding a chloroplast-targeted protein
10. Intensive Induction Therapy with Behenoyl, Cytosine Arabinoside, Daunorubicin, and 6-Mercaptopurine Followed by Intensive Consolidation with Mitoxantrone, Etoposide, Vincristine, and Intermediate-Dose Continuous Cytarabine (M-85 Protocol) for Adult Acute Myelogenous Leukemia
11. Expression of a cold-responsive Lt-Cor gene and development of freezing tolerance during cold acclimation in wheat (Triticum aestivum L.)
12. Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia
13. CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells
14. A new HTS cable project in Japan
15. Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial
16. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome
17. Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells
18. Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype
19. The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype
20. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate
21. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
22. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
23. Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
24. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
25. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy
26. Clinicopathologic characteristics of leukemia in Japanese children and young adults
27. In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity and reduction in WT1 gene expression
28. Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines
29. Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin
30. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia
31. Multidrug resistance pglycoprotein function of bone marrow hematopoietic cells and the reversal agent effect
32. Extensive cytogenetic studies of clonality following interferon-α therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic
33. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells
34. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
35. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
36. Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission
37. Characterization of the immunoglobulin light chain variable region gene expressed in multiple myeloma
38. Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia
39. Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia
40. Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARα and its down-regulation in acute promyelocytic leukemia
41. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia
42. Comparison of the immunoglobulin gene transcripts between immature B lineage acute lymphoblastic leukemia and the normal phenotypic counterparts in the bone marrow
43. Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21)
44. Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations
45. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate
46. Performance of a new Schottky CdTe detector for hard X-ray spectroscopy
47. P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelocytic leukemia cells
48. Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia
49. Large-area CdTe diode detector for space application
50. A Double-blind Controlled Study of G-CSF Started Two Days Before Induction Chemotherapy in Refractory Acute Myeloid Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.